Radiotherapy for inoperable pancreatic cancer can be limited by toxicity due to the proximity and interfraction variability of the adjacent luminal gastrointestinal organs-at-risk (GI-OARs). We investigated the role of daily adaptive MRI guided radiation therapy (MR-IGRT) to adjust for interfraction motion and allow dose-escalated pancreatic radiotherapy.